Treatment options for rosacea with concomitant conditions

Nurse Practitioner

Volumn 36, Issue 2, 2011, Pages 24-31

  Roebuck, Heather ^a  

^a The Dermatology Group   (United States)

Author keywords

Rosacea and concomitant skin disorders; Rosacea management; Seborrheic dermatitis

Indexed keywords

ARTICLE; HUMAN; ROSACEA; SKIN DISEASE;

HUMANS; ROSACEA; SKIN DISEASES;

EID: 79956209964     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000392794.17007.36     Document Type: Article

References (35)

1. National Rosacea Society; 2007.
2. Feldman SR, Hollar CB, Gupta AK, Fleischer AB Jr. Women commonly seek care for rosacea: dermatologists frequently provide the care. Cutis. 2001;68(2):156-160.
3. Schittek B, Paulmann M, Senyürek I, Steffen H. The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets. 2008;8(3):135-143.
4. Gilliet M, Lande R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol. 2008;20(4):401-407.
5. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975-980.
6. Buechner SA. Rosacea: an update. Dermatology. 2005;210(2):100-108.
7. Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007;157(3):474-481.
8. Rosacea.org. Rosacea review; 2007.
9. Manual MM. Merck and the Merck Manuals. The Merck Manual Medical Library; 2008.
10. Bikowski J. Facial seborrheic dermatitis: a report on current status and therapeutic horizons. J Drugs Dermatol. 2009;8(2):125-133.
11. Bolognia JJ, Rapini RP. Dermatology. Vol 2. 2nd ed. Philadelphia: Elsevier Limited; 2008.
12. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol. 2005;19(3):273-285.
13. International Rosacea Foundation. What is rosacea? 2010.
14. Roebuck HL. Face up to rosacea. Nurse Pract. 2005;30(9):24-30, 35; quiz 36-37.
15. Draelos Z, Kayne AL. Implications of azelaic acid's multiple mechanisms of action: therapeutic versatility. Poster 443. Paper presented at: American Academy of Dermatology 66th Annual Meeting; 2008; San Antonio, TX.
16. Trumbore MW, Goldstein JA, Gurge RM. Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam. J Drugs Dermatol. 2009;8(3):299-304.
17. Laquieze S, Czernielewski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatolog Treat. 2007;18(3):158-162.
18. Draelos ZD. The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea. Cutis. 2006;77(4 suppl):27-33.
19. Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. Cutis. 2005;75(3 suppl):17-21; discussion 33-36.
20. Mills K, Suszcynsky-Meister E, Kincaid E, Copas E. Ceramide insufficiency in dandruff/seborrheic stratum corneum is reversed by potentiated micronized platelet pryithione zinc shampoo treatment (poster). J Am Acad Dermatol. 2008;58(suppl 2).
21. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 suppl):S1-S37.
22. Del Rosso JQ. Highlights from the latest acne treatment guidelines. practical and clinical issues in dermatology; 2007.
23. Katsambas AD, Nicolaidou E. Acne, perioral dermatitis, flushing, and rosacea: unapproved treatments or indications. Clin Dermatol. 2000;18(2):171-176.
24. Kuflik JH, Janniger CK, Piela Z. Perioral dermatitis: an acneiform eruption. Cutis. 2001;67(1):21-22.
25. Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150(6):1136-1141.
26. Hafeez ZH. Perioral dermatitis: an update. Int J Dermatol. 2003;42(7):514-517.
27. Ting PT, Barankin B. Dermacase. Perioral dermatitis. Can Fam Physician. 2007;53(7):1157, 1165.
28. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048-1065.
29. Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308-313.
30. Graupe K, Verallo-Rowell V, Verallo V, Zaumseil RP. Combined use of 20% azelaic acid and 0.05% tretinoin cream in topical treatment of melasma. J Dermatol Treat. 1996;7:235-237.
31. Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol. 1998;37(12):897-903.
32. Balkrishnan R, McMichael AJ, Hu JY, et al. Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol. 2006;45(2):111-115.
33. Matsuoka Y, Yoneda K, Sadahira C, Katsuura J, Moriue T, Kubota Y. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris. J Dermatol. 2006;33(11):745-752.
34. Boehncke WH, Ochsendorf F, Paeslack I, Kaufmann R, Zollner TM. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol. 2002;12(6):577-580.
35. National Rosacea Society. Rosacea Triggers Survey; 2010.